Nucleate is excited to welcome Alexandra S. Bause for our first Venture Creation Spotlight event Wednesday at 1PM ET / 10AM PT. She will speak on the origin of Samsara Therapeutics, a company hunting for small molecule activators of autophagy @ApolloHealthVC. Register below! 👇

Expanding our team!theoxfordtrust.co.uk/samsara-therap…

We’re pleased to report that we’ve further strengthened our team in Oxford, adding iPS cell capabilities, more screening expertise and administration support. All to help move our promising pipeline into the clinic. samsaratherapeutics.com/more-additions…

This is exciting - a really high powered SAB for Samsara, to help us move into the clinic with disease modifying therapeutics:x.com/samsaratx/stat…

Great new facilities for cell culture to support our move into iPS cell models from patients - Parkinson's Disease, ALS and also rare monogenic diseases. Thanks again due to the Oxford Trust!

This nature article from Elie Dolgin talks about how private companies and academia are now pushing to target #autophagy with drugs for #healthy #ageing (#aging) and treatment of age-related #disease. Look out for my quote😉 SAHMRI nature.com/articles/d4158…

Nice Nature review on autophagy, with a few quotes from us: nature.com/articles/d4158…

theoxfordtrust.co.uk/samsara-therap…

Putting #autophagy front and centre in #longevity drug development Samsara prepares for clinical trials of autophagy-inducing drugs for age-related diseases. Samsara Therapeutics Peter Hamley #biotech #cellularhealth longevity.technology/news/putting-a…

We're delighted to announce our new partnership with the Charcot Marie Tooth Research Foundation, to develop our novel autophagy approach for CMT1A: samsaratherapeutics.com/cmt-research-f… cmtrf.org/samsara-therap…

linkedin.com/posts/geraldin…

I am interviewed in the national press today about our candidate molecule for Parkinson's Disease: x.com/samsaratx/stat…

We're excited to unveil our promising autophagy drug candidate SAM001 which will be the first agent of its class to enter clinical trials, offering new hope for people with Parkinson’s and Motor Neurone Disease (ALS): samsaratherapeutics.com/samsara-therap…

It was great to chat to BBC Radio Oxford today about autophagy, our Parkinson's disease drug candidates and the support of The Michael J Fox Foundation for Parkinson’s Research. youtube.com/watch?v=uvLnB8…

Read my article on the new drugs available for neurodegeneration and what the future holds: x.com/samsaratx/stat…

We have exciting news – we are FINALISTS of the Best Ermerging Biotech category for the @OBN 2023 #OBNAwards. Join us at The Royal Lancaster in London on November 22nd. Find out more at obn-awards.com #lifesciences #innovation #achievement #celebration

Samsara Therapeutics' CSO Peter Hamley talks to Drug Discovery World about the potential of boosting autophagy in neurodegenerative diseases and beyond: ddw-online.com/turning-scienc…

2023 has brought promising developments in the field of Alzheimer’s - our CSO Peter Hamley chats to Health Tech World about what these mean for patients and why Samsara is keeping its foot on the gas in the search for new treatments: x.com/healthtechworl…

Curious as to how boosting autophagy could help in rare disease treatment? Follow the link to Samsara Chief Scientific Officer, Peter Hamley’s article in Drug Target Review: drugtargetreview.com/article/111762…

Thrilled and proud to win the Best Emerging Biotech category at the #OBNAwards! x.com/OBN_UK/status/…